Ovidiu-Dumitru Ilie, Raluca Duta, Ilinca-Bianca Nita, Irina Dobrin, Irina-Luciana Gurzu, Irina Girleanu, Laura Huiban, Cristina Muzica, Alin Ciobica, Roxana Popescu, Petru Cianga, Carol Stanciu, Diana Cimpoesu, Anca Trifan
Background: Hepatic encephalopathy (HE) caused by cirrhosis has severe consequences on an individual's lifespan, leading to long-term liver complications and potentially life-threatening outcomes. Despite recent interest in this condition, the effectiveness of secondary prophylaxis involving rixafimin, lactulose, or L-ornithine L-aspartate (LOLA) may be hindered by the unique microbial profiles each patient possesses. Methods: Thus, in this manuscript, we aimed to search, identify, and gather all randomized controlled trials (RCTs) published between 2000-2023 (November) in four major academic databases such as PubMed, ISI Web of Science, Scopus, and ScienceDirect by using a controlled terminology and web strings that reunite six main keywords...
December 10, 2023: Medicina